Artificial Intelligence: Merck KGaA, Darmstadt, Germany, to develop automated Diagnostic Tool for Neglected Tropical Diseases together with Janssen
02 JUL 2020
Combined efforts aim to develop an Artificial Intelligence (AI) technology that detects both schistosomiasis and soil-transmitted helminthiasis
Merck KGaA, Darmstadt, Germany, has entered into a strategic partnership with Janssen Pharmaceutica, N.V., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, to develop an AI based diagnostic tool to improve detection of the Neglected Tropical Diseases (NTDs) schistosomiasis and soil-transmitted helminthiasis.
This AI technology has the potential to improve diagnostic efficiency, data accuracy and decision making for mass drug administration programs.
Please read more through the Press Release